Article Information
vol. 8 no. 326 326ra20
- Received for publication October 30, 2015
- Accepted for publication January 8, 2016
- .
Author Information
- Olivier Burgy1,2,3,*,
- Guillaume Wettstein1,2,3,*,
- Pierre S. Bellaye1,2,3,
- Nathalie Decologne3,4,
- Cindy Racoeur3,4,
- Françoise Goirand1,2,3,
- Guillaume Beltramo1,2,3,5,
- Jean-François Hernandez6,
- Abderraouf Kenani7,
- Philippe Camus1,2,3,5,
- Ali Bettaieb3,4,
- Carmen Garrido1,2,3,8,† and
- Philippe Bonniaud1,2,3,5,†,‡
- 1INSERM, LNC UMR 866, Laboratoire d’Excellence LipSTIC, Dijon 21079, France.
- 2Equipe “Heat Shock Proteins” Labellisée par la Ligue Nationale contre le Cancer, Dijon 21079, France.
- 3Faculty of Medicine and Pharmacy of Dijon, Université Bourgogne Franche-Comté, Dijon 21079, France.
- 4EPHE, Tumor Immunology and Immunotherapy Laboratory, Dijon 21079, France.
- 5Service de Pneumologie et Soins Intensifs Respiratoires, Centre Hospitalier Universitaire (CHU), Dijon 21079, France.
- 6Institut des Biomolécules Max Mousseron, Faculty of Pharmacy, University of Montpellier, Montpellier 34093, France.
- 7Department of Biochemistry, University of Monastir, Monastir 5000, Tunisia.
- 8Anticancer Centre Georges François Leclerc, CGFL, Dijon 21079, France.
- ↵‡Corresponding author. E-mail: philippe.bonniaud{at}chu-dijon.fr